Suo Z - Search Results

1

Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.

Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM. Wu D, et al. Among authors: suo z. Gynecol Oncol. 2004 Aug;94(2):312-9. doi: 10.1016/j.ygyno.2004.05.019. Gynecol Oncol. 2004. PMID: 15297167

2

Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.

Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE. Goscinski MA, et al. Oncology. 2008;75(1-2):49-59. doi: 10.1159/000151741. Epub 2008 Sep 12. Oncology. 2008. PMID: 18787344

3

Expression of Ephb2 and Ephb4 in breast carcinoma.

Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM. Wu Q, et al. Among authors: suo z. Pathol Oncol Res. 2004;10(1):26-33. doi: 10.1007/BF02893405. Epub 2004 Mar 18. Pathol Oncol Res. 2004. PMID: 15029258 Free article.

4

Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.

Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z. Wu D, et al. Among authors: suo z. Pathol Oncol Res. 2004;10(4):212-8. doi: 10.1007/BF03033763. Epub 2004 Dec 27. Pathol Oncol Res. 2004. PMID: 15619642 Free article.

5

The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.

Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z. Han L, et al. Among authors: suo z. Gynecol Oncol. 2005 Nov;99(2):278-86. doi: 10.1016/j.ygyno.2005.06.036. Epub 2005 Aug 2. Gynecol Oncol. 2005. PMID: 16061279

6

Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

Xu F, Zhong W, Li J, Shanshen Z, Cui J, Nesland JM, Suo Z. Xu F, et al. Among authors: suo z. Anticancer Res. 2005 Jul-Aug;25(4):2943-50. Anticancer Res. 2005. PMID: 16080548 Free article.

7

The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.

Wu Q, Suo Z, Kristensen GB, Baekelandt M, Nesland JM. Wu Q, et al. Among authors: suo z. Gynecol Oncol. 2006 Jul;102(1):15-21. doi: 10.1016/j.ygyno.2005.11.034. Epub 2006 Feb 23. Gynecol Oncol. 2006. PMID: 16499955

8

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.

Holm R, de Putte GV, Suo Z, Lie AK, Kristensen GB. Holm R, et al. Among authors: suo z. Int J Med Sci. 2008 Jun 5;5(3):121-6. doi: 10.7150/ijms.5.121. Int J Med Sci. 2008. PMID: 18566674 Free PMC article.

9

The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.

Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R. Wang Z, et al. Among authors: suo z. BMC Cancer. 2008 Oct 24;8:308. doi: 10.1186/1471-2407-8-308. BMC Cancer. 2008. PMID: 18950492 Free PMC article.

10

Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.

Wang Q, He W, Lu C, Wang Z, Wang J, Giercksky KE, Nesland JM, Suo Z. Wang Q, et al. Among authors: suo z. Anticancer Res. 2009 Apr;29(4):1233-41. Anticancer Res. 2009. PMID: 19414369 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

637 results

Search Page

Filters